Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia
Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia: A Prospective Randomized Trial
Sponsor: Daniel Stephan Engeler
This NA trial investigates Benign Prostatic Hyperplasia and is currently completed. Daniel Stephan Engeler leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2021 — Jan 2023 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Sep 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Sep 2017 [monthly]
Recruiting NA
First recorded
Feb 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Daniel Stephan Engeler
For direct contact, visit the study record on ClinicalTrials.gov .